Cancer Research Cancer Epigenetics  Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tien, E. S.
Right arrow Articles by Vanden Heuvel, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tien, E. S.
Right arrow Articles by Vanden Heuvel, J. P.
[Cancer Research 63, 5767-5780, September 15, 2003]
© 2003 American Association for Cancer Research


Regular Articles

Comprehensive Gene Expression Analysis of Peroxisome Proliferator-treated Immortalized Hepatocytes

Identification of Peroxisome Proliferator-activated Receptor {alpha}-dependent Growth Regulatory Genes1

Eric S. Tien, Joshua P. Gray, Jeffrey M. Peters and John P. Vanden Heuvel2

Department of Veterinary Science, Center for Molecular Toxicology and Carcinogenesis, Pennsylvania State University, University Park, Pennsylvania 16802

Chemicals known as peroxisome proliferators (PPs) are the subject of intense study because of their ability to cause hepatocellular carcinoma in laboratory rodents. These chemicals act through a family of proteins termed the peroxisome proliferator-activated receptors (PPARs), in particular PPAR{alpha}. It has become increasingly apparent that the role of the PPs in the development of cancer encompasses many different aspects of cell growth regulation. Immortalized hepatocytes from wild-type (PPAR{alpha}+/+) and PPAR{alpha}-/- mice were generated using a temperature-sensitive SV40 virus. Characterization of the murine SV40 hepatocytes (MuSH) generated from both genotypes (MuSH{alpha}+/+, MuSH{alpha}-/-) show markers of differentiation such as albumin expression, but is devoid of Kupffer cell contamination. Hallmark PPAR{alpha}-mediated responses such as induction of acyl-CoA oxidase mRNA by PPs are present in the MuSH{alpha}+/+ but are absent in MuSH{alpha}-/- cells. In contrast to most cell culture systems, the wild-type MuSH hepatocytes retain the mitogenic activity of PPs, whereas the MuSH{alpha}-/- does not respond in this manner, thus making this cell culture system an ideal tool to examine growth regulatory gene expression affected by PPs. Microarray experiments performed on both cell types identified many genes in which regulation is dependent on the presence of PPAR{alpha}, and these changes were verified with reverse transcriptase-PCR. Genes involved in carcinogenesis and control of the cell cycle that are regulated by PPs in a PPAR{alpha}-dependent manner include ubiquitin COOH-terminal hydrolase 37 (also known as UCT-L5) and cyclin T1. These results show that MuSH cells reflect the biological properties of both the wild-type and PPAR{alpha}-null animals and can be used to identify novel PPAR{alpha}-regulated genes that could be involved in regulation of the cell cycle and carcinogenesis.




This article has been cited by other articles:


Home page
Toxicol SciHome page
L. Gopinathan, D. B. Hannon, J. M. Peters, and J. P. Vanden Heuvel
Regulation of Peroxisome Proliferator-Activated Receptor-{alpha} by MDM2
Toxicol. Sci., March 1, 2009; 108(1): 48 - 58.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
C. G. Woods, J. P. Vanden Heuvel, and I. Rusyn
Genomic Profiling in Nuclear Receptor-Mediated Toxicity
Toxicol Pathol, June 1, 2007; 35(4): 474 - 494.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
C. R. Santos, M. Rodriguez-Pinilla, F. M. Vega, J. L. Rodriguez-Peralto, S. Blanco, A. Sevilla, A. Valbuena, T. Hernandez, A. J. van Wijnen, F. Li, et al.
VRK1 Signaling Pathway in the Context of the Proliferation Phenotype in Head and Neck Squamous Cell Carcinoma
Mol. Cancer Res., March 1, 2006; 4(3): 177 - 185.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J. P. Gray, J. W. Davis II, L. Gopinathan, T. L. Leas, C. A. Nugent, and J. P. Vanden Heuvel
The Ribosomal Protein rpL11 Associates with and Inhibits the Transcriptional Activity of Peroxisome Proliferator-Activated Receptor-{alpha}
Toxicol. Sci., February 1, 2006; 89(2): 535 - 546.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
P. B. Mann, K. D. Elder, M. J. Kennett, and E. T. Harvill
Toll-Like Receptor 4-Dependent Early Elicited Tumor Necrosis Factor Alpha Expression Is Critical for Innate Host Defense against Bordetella bronchiseptica
Infect. Immun., November 1, 2004; 72(11): 6650 - 6658.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. S. Tien, J. W. Davis, and J. P. Vanden Heuvel
Identification of the CREB-binding Protein/p300-interacting Protein CITED2 as a Peroxisome Proliferator-activated Receptor {alpha} Coregulator
J. Biol. Chem., June 4, 2004; 279(23): 24053 - 24063.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.